CCL5 and cancer: Although chemokine expression in PNETs has been poorly studied, upstream signaling pathways including NF-κB and canonical cyclic GMP-AMP synthase/stimulator of interferon genes (STING) pathways have been shown to regulate CCR5 and CCL5 expression in other types of cancer (46).